TY - JOUR
T1 - Pharmacology of flavor preference conditioning in sham-feeding rats
T2 - Effects of dopamine receptor antagonists
AU - Yu, Wei Zhen
AU - Silva, Robert M.
AU - Sclafani, Anthony
AU - Delamater, Andrew R.
AU - Bodnar, Richard J.
N1 - Funding Information:
This research was supported in part by a CUNY Collaborative Incentive Grant (991995) to A.S., A.D., and R.J.B. A.S. was supported by a National Institute of Mental Health Scientist Award (MH-00983).
PY - 2000/4
Y1 - 2000/4
N2 - Opioid and dopamine systems are both implicated in the response to sweet solutions. Our laboratory previously reported that the opioid antagonist, naltrexone, reduced the intake of sweet solutions, yet had little or no effect on sucrose-conditioned flavor preferences in sham-feeding rats. The present study examined the role of dopamine D1 and D2 receptors in the expression of flavor preferences conditioned by the sweet taste of sucrose. All sessions were conducted under sham-feeding conditions to minimize postingestive influences. Training was accomplished by adding a novel flavor (CS+) to a 16% sucrose solution, a different flavor (CS-) to a less-preferred 0.2% saccharin solution in alternating, one-bottle sessions. Preferences were assessed in two-bottle tests with the CS+ and CS- flavors presented in mixed sucrose (8%)-saccharin (0.1%) solutions following systemic doses of 0, 50, 200, 400, or 800 nmol/kg of the D2 antagonist, raclopride (Experiment 1) or the D1 antagonist, SCH23390 (Experiment 2) under either food-restricted or unrestricted conditions. Rats significantly preferred the CS+ solutions in vehicle tests, and displayed equipotent and dose-dependent reductions in total intake and CS+ preference following either D1 or D2 receptor antagonism. Similar results were obtained with SCH23390 and raclopride in Experiment 3 conducted with water-restricted rats. These data indicate that dopaminergic D1 and D2 receptors play pivotal and functionally equivalent roles in the expression of flavor preferences conditioned by the sweet taste of sucrose. Copyright (C) 2000 Elsevier Science Inc.
AB - Opioid and dopamine systems are both implicated in the response to sweet solutions. Our laboratory previously reported that the opioid antagonist, naltrexone, reduced the intake of sweet solutions, yet had little or no effect on sucrose-conditioned flavor preferences in sham-feeding rats. The present study examined the role of dopamine D1 and D2 receptors in the expression of flavor preferences conditioned by the sweet taste of sucrose. All sessions were conducted under sham-feeding conditions to minimize postingestive influences. Training was accomplished by adding a novel flavor (CS+) to a 16% sucrose solution, a different flavor (CS-) to a less-preferred 0.2% saccharin solution in alternating, one-bottle sessions. Preferences were assessed in two-bottle tests with the CS+ and CS- flavors presented in mixed sucrose (8%)-saccharin (0.1%) solutions following systemic doses of 0, 50, 200, 400, or 800 nmol/kg of the D2 antagonist, raclopride (Experiment 1) or the D1 antagonist, SCH23390 (Experiment 2) under either food-restricted or unrestricted conditions. Rats significantly preferred the CS+ solutions in vehicle tests, and displayed equipotent and dose-dependent reductions in total intake and CS+ preference following either D1 or D2 receptor antagonism. Similar results were obtained with SCH23390 and raclopride in Experiment 3 conducted with water-restricted rats. These data indicate that dopaminergic D1 and D2 receptors play pivotal and functionally equivalent roles in the expression of flavor preferences conditioned by the sweet taste of sucrose. Copyright (C) 2000 Elsevier Science Inc.
KW - Conditioned flavor preference
KW - D receptor
KW - D receptor SCH23390
KW - Dopamine
KW - Expression studies
KW - Raclopride
KW - Sham-feeding preparation
UR - http://www.scopus.com/inward/record.url?scp=0034025748&partnerID=8YFLogxK
U2 - 10.1016/S0091-3057(99)00239-7
DO - 10.1016/S0091-3057(99)00239-7
M3 - Article
C2 - 10764916
AN - SCOPUS:0034025748
SN - 0091-3057
VL - 65
SP - 635
EP - 647
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 4
ER -